Wird geladen...
Management of atypical chronic lymphocytic leukemia presenting with extreme leukocytosis
Atypical chronic lymphocytic lymphoma (CLL) with CCND1 translocation is poorly described, particularly in the era of modern inhibitors of the B‐cell receptor pathway. We present a patient with atypical CLL who had a significant response to ibrutinib, highlighting the effectiveness of this agent in h...
Gespeichert in:
| Veröffentlicht in: | Clin Case Rep |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
John Wiley and Sons Inc.
2020
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7250984/ https://ncbi.nlm.nih.gov/pubmed/32477538 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ccr3.2773 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|